Alnylam Pharmaceuticals (A1LN34.SA) Q4 2015 Earnings

9NovConfirmed
Q1 2015
Q2 2015
Q3 2015
Q4 2015
-3.57
-2.64
-1.72
-0.79

Details

Expected EPS
-3.5684279999999995
Actual EPS
-3.454542
Surprise EPS
0.11
Surprise Percent
+3.19%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -3.454542 per share for Q4 2015.

0 Comments

Share your thoughts